QGEN Stock Analysis: Buy, Sell, or Hold?
QGEN - QIAGEN N.V.
$41.40
-0.05 (-0.12%)
▼
5d:
+0.07%
30d:
+5.8%
90d:
+19.72%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Get Alerted When QGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: QGEN shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: QGEN shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.15
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$34.24
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QGEN is currently trading at $41.40, which is considered slightly high relative to its 30-day fair value range of $38.75 to $41.75. The stock's valuation (Forward PE: 15.8) is in line with its historical norms (15.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, QGEN is in a uptrend. The price is approaching resistance at $42.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QGEN is in a uptrend. The price is approaching resistance at $42.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$38.75 -
$41.75
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($44.07)
Trading Range Analysis
30-Day Trading Range
$38.75 -
$41.75
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$39.36
Resistance Level
$42.42
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.80
Wall Street Target
$44.07
(+6.3%)
Revenue Growth (YoY)
1.8%
Earnings Growth (YoY)
-23.8%
Profit Margin
19.2%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
15.8 vs 15.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$41.37
(0%)
2-Year Target
$41.28
(0%)
3-Year Target
$41.20
(-1%)
3-Yr Target (if PE normalizes)
(PE: 16→16)
$41.46
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 7.5%)
$67.75
(+64%)
Base:
(SPY PE: 15.8, Growth: 7.5%)
$51.44
(+24%)
Bear:
(PE: 13.4, Growth: 7.5%)
$43.72
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 21.33 | Current EPS (TTM): $1.96
Bull Case
$61.56
(+49%)
Analyst growth 33.8%, PE expands to 23.5
Base Case
$55.96
(+35%)
Market implied 33.8%, PE stable at 21.3
Bear Case
$28.43
(-31%)
Severe decline -20.0%, PE contracts to 18.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.8 to 15.9
Stabilization Target:
$41.71
(+0.6%)
PE Expansion Potential:
+0.6%
Share & Embed Analysis
Last updated: August 02, 2026 9:27 PM ET
Data refreshes hourly during market hours. Next update: 10:27 PM
Data refreshes hourly during market hours. Next update: 10:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
